Lv11
70 积分 2025-03-31 加入
Integrin α2 promotes immune escape in non-small-cell lung cancer by enhancing PD-L1 expression in exosomes to inhibit CD8 + T-cell activity
3小时前
已完结
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
23天前
已关闭
A phosphatase-recruiting bispecific antibody-aptamer chimera for enhanced suppression of tumor growth
1个月前
已完结
Molecular mechanism of IgE-mediated FcεRI activation
1个月前
已完结
Structural insights into the high-affinity IgE receptor FcεRI complex
1个月前
已完结
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
CD19 structure, expression, and signaling: From basic mechanisms to therapeutic targeting
1个月前
已完结
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1个月前
已完结
皖公网安备34019202002308
